Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Faran is a leading Greek pharmaceutical company founded in 1950, dedicated to providing the Greek medical community with high-quality therapeutic options. The company specializes in the commercialization of innovative medicines, biosimilars, and branded generics across diverse therapeutic areas such as oncology, hematology, nephrology, and rheumatology. Faran has established long-term strategic alliances with global pharmaceutical leaders, including Novartis, Amgen, and Sandoz, to expand its portfolio and ensure patient access to advanced treatments. Headquartered in Kifissia, the company leverages its extensive market expertise and robust distribution network to maintain a significant presence in the Greek healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Faran Laboratories.